Molecule of the year
At their core, biochemistry and molecular biology are all about how molecules interact.
Molecules catalyze reactions, form structural components and help carry important signals from one end of a system to the other. Proteins, nucleic acids, lipids, carbohydrates, metabolites and small molecules all play important roles in the vast network of life’s processes.
We invite you to nominate what you consider to be the most influential molecular discoveries and innovations for our inaugural "Molecule of the Year" contest.
Here’s how it works:
- From now until May 17, you can submit your nomination for the molecule of the year.
- From May 27 until June 14, all ASBMB members will have the chance to vote for the molecule they think is deserving of the title “Molecule of the Year.”
This is your chance to recognize the discoveries at the heart of groundbreaking advancements, whether it's a revolutionary drug, an important metabolite or an incredible enzyme. Nominate your choice for the Molecule of the Year and let's shine a spotlight on the molecules that make the world go round.
Questions? Contact Joanna Kotloski, membership director.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.
Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.
Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.
The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.
Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.
Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.